RxSight
RXST
RXST
45 hedge funds and large institutions have $108M invested in RxSight in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+5
Holders Change %
+12.5%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
21
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$11.7M |
| 2 |
2
BlackRock
New York
|
$9.11M |
| 3 |
CAM
3
Cresset Asset Management
Chicago,
Illinois
|
$3.91M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$7.91M |
| 5 |
BM
5
Bridger Management
New York
|
$2.46M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GCM
51
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$113K | -10,000 | Closed |
|
52
Marshall Wace
London,
United Kingdom
| – | -$68K | -6,034 | Closed |
|